How to Get Armour Thyroid in Delaware

What Armour Thyroid Is and Why Delaware Patients Request It

Armour Thyroid is a prescription porcine-derived desiccated thyroid extract (DTE) that contains both T4 (levothyroxine) and T3 (liothyronine) in a roughly 4:1 ratio by weight. Each 60 mg grain contains approximately 38 mcg T4 and 9 mcg T3. That dual-hormone profile is the primary reason patients and some clinicians prefer it over synthetic levothyroxine monotherapy, which supplies T4 alone and depends on peripheral conversion to produce active T3.

A 2013 head-to-head crossover trial by Hoang et al. (N=70) published in the Journal of Clinical Endocrinology and Metabolism found that 49% of participants preferred DTE over levothyroxine after a direct switch, and patients on DTE lost a mean of 0.35 kg more body weight during the DTE treatment period (1). Preference did not break along any single demographic line, which means the right candidate is identified by symptom pattern and lab response rather than age or sex alone.

Delaware has no state-specific statute restricting DTE prescribing. Any provider with Delaware prescriptive authority who believes the clinical evidence supports its use in a given patient may write the prescription.

The HealthRX clinical team uses a four-gate framework before recommending Armour Thyroid to Delaware patients:

1. Confirmed hypothyroidism (TSH above the laboratory reference range on two separate draws, or a single TSH >10 mIU/L with symptoms)
2. Persistent symptoms on optimized levothyroxine despite TSH in the lower half of the reference range, or documented intolerance to synthetic T4
3. No contraindication to T3 exposure (uncontrolled angina, recent myocardial infarction within 6 months, or untreated adrenal insufficiency rule out DTE)
4. Patient understanding that DTE dosing requires more frequent early titration checks (at 6 weeks rather than the standard 8 to 12 weeks used for levothyroxine)

This framework is not a diagnostic algorithm; it is a pre-consultation screening tool HealthRX clinicians use to identify which patients are likely to benefit from a DTE conversation rather than a straight levothyroxine dose adjustment.

Step-by-Step: How to Get an Armour Thyroid Prescription in Delaware

Getting Armour Thyroid in Delaware follows a predictable path. The steps below apply whether you use an in-person endocrinologist, a primary care provider, or a telehealth platform licensed in Delaware.

Step 1. Order or bring baseline labs. No responsible prescriber will initiate DTE without thyroid function testing. The minimum panel is TSH and Free T4. Most DTE-prescribing clinicians also order Free T3 and, if adrenal issues are suspected, a morning cortisol. Lab orders can be placed by any Delaware-licensed provider; if you are starting with a telehealth platform, most will send an electronic order to a Quest or LabCorp draw site near you before the consultation itself.

Step 2. Schedule a consultation. In-person options include endocrinologists at ChristianaCare Health System in Newark or Wilmington, or primary care practices across all three counties (New Castle, Kent, and Sussex). Telehealth consultations are legally valid in Delaware under the Delaware Telehealth Act (Title 24, Chapter 1, Delaware Code), which allows prescribing after a synchronous audio-video visit with no required prior in-person relationship (2).

Step 3. Receive the prescription. Delaware does not restrict DTE to a specific prescriber class. MDs, DOs, NPs with full prescriptive authority, and PAs with a valid supervising agreement may all write the prescription. The prescription may be transmitted electronically to any Delaware-licensed retail or compounding pharmacy, or to a mail-order pharmacy licensed to ship into Delaware.

Step 4. Fill at a pharmacy or 503A compounder. Standard Armour Thyroid tablets (15 mg, 30 mg, 60 mg, 90 mg, 120 mg, 180 mg, 240 mg, and 300 mg strengths) are available at most major retail chains in Delaware, including CVS, Walgreens, and Rite Aid locations across Wilmington, Dover, and Newark. If a specific strength is on back order, a Delaware-licensed 503A compounding pharmacy may prepare NDT capsules in a custom dose (see the 503A section below).

Step 5. Confirm titration follow-up before you leave. The FDA-approved labeling for Armour Thyroid specifies that thyroid function should be assessed 6 weeks after any dose change (3). Book that follow-up appointment before you fill your first prescription.

Telehealth Providers Prescribing Armour Thyroid in Delaware

Delaware telehealth law permits a Delaware-licensed clinician to initiate a new controlled or non-controlled prescription following a synchronous audio-video encounter, provided the clinician documents a valid patient-provider relationship and a clinical evaluation. Armour Thyroid is not a controlled substance, so no DEA telemedicine exception is required.

Several national telehealth platforms hold Delaware licenses and have clinical protocols that include DTE as a treatment option. HealthRX operates in Delaware and, after reviewing labs and conducting a video consultation, can issue an Armour Thyroid prescription on the same day as the visit for qualifying patients. The prescription is sent electronically to the patient's preferred Delaware pharmacy or to a mail-order pharmacy that ships to all Delaware zip codes.

When comparing telehealth providers, ask three specific questions before booking:

• Does the platform's protocol permit DTE as a first-line alternative, or only as a second-line after documented levothyroxine failure?
• Will the prescribing clinician order Free T3 (not just TSH and Free T4) to establish a pre-treatment baseline?
• Does the platform include a 6-week titration check in the visit package, or is that billed separately?

A 2019 analysis published in JAMA Internal Medicine found that patients who received specialist-level thyroid care via telehealth reported equivalent satisfaction scores and achieved target TSH ranges at similar rates to in-person care cohorts over 12 months (4).

Labs Required Before Armour Thyroid in Delaware

Your prescriber needs objective data. Symptom reports alone are not sufficient to initiate DTE therapy under any responsible clinical protocol.

The standard pre-treatment panel includes:

• TSH (thyrotropin): The primary diagnostic marker. A TSH above the upper reference limit (typically 4.5 to 5.0 mIU/L depending on the lab) combined with symptoms confirms primary hypothyroidism.
• Free T4: Differentiates primary from secondary hypothyroidism and establishes a pre-treatment baseline.
• Free T3: Not universally required for levothyroxine initiation, but standard practice before DTE because DTE supplies exogenous T3 directly. A pre-treatment Free T3 below the low end of the reference range supports the rationale for a dual-hormone approach.
• TPO antibodies (anti-TPO): Ordered if Hashimoto thyroiditis is suspected. Presence of antibodies does not change the DTE prescribing decision but affects long-term monitoring frequency.
• Morning cortisol (8 a.m. serum): Ordered if the patient has symptoms suggesting adrenal insufficiency (fatigue, hypotension, hyperpigmentation). Unrecognized adrenal insufficiency is the principal safety concern with DTE initiation because T3 accelerates cortisol clearance.

The American Thyroid Association 2014 guidelines for hypothyroidism management note that "measurement of serum TSH is the single best screening test for primary thyroid dysfunction in ambulatory patients" and that Free T3 assessment adds clinical value when symptoms persist despite normalized TSH (5). Delaware labs at LabCorp and Quest turn around standard thyroid panels in 24 to 48 hours for most patients.

Who Can Prescribe Armour Thyroid in Delaware

Three practitioner types hold prescriptive authority in Delaware that covers Armour Thyroid:

MDs and DOs. Full prescriptive authority without supervision requirements. Endocrinologists and internal medicine physicians represent the most common prescribers of DTE in Delaware, though family medicine physicians increasingly prescribe it as well.

Nurse Practitioners (NPs). Delaware grants NPs full practice authority (FPA) under Senate Bill 59 enacted in 2015. Delaware NPs do not require a supervising physician agreement to prescribe and may initiate Armour Thyroid independently after appropriate evaluation.

Physician Assistants (PAs). Delaware PAs prescribe under a written agreement with a supervising physician. The agreement must authorize thyroid medication prescribing; most general supervising agreements do. PAs cannot prescribe outside the scope of the supervising agreement.

Naturopathic doctors (NDs) do not hold prescriptive authority for legend drugs in Delaware and cannot write a valid Armour Thyroid prescription.

Delaware Medicaid Coverage and Prior Authorization

Delaware Medicaid (known as Diamond State Health Plan and Diamond State Health Plan Plus, administered by managed care organizations) lists Armour Thyroid as a covered drug for hypothyroidism with prior authorization. Prior authorization is not automatic; your prescriber submits a PA request on your behalf.

A standard Delaware Medicaid PA submission for Armour Thyroid typically requires:

1. A confirmed diagnosis of hypothyroidism (ICD-10: E03.9 or E06.3 for Hashimoto thyroiditis with hypothyroidism)
2. Documentation of at least one 30 to 90-day trial of levothyroxine or liothyronine with documented inadequate response or intolerance, OR a clinical narrative explaining why synthetic monotherapy is not appropriate
3. Current thyroid function labs (TSH and Free T4 dated within the past 6 months)
4. Prescriber attestation that the prescribed dose is consistent with the patient's weight and current thyroid status

Processing time for Delaware Medicaid PA requests ranges from 3 to 7 business days for standard reviews and 24 to 72 hours for urgent clinical reviews. If PA is denied, the prescriber may file a Level 1 internal appeal within 30 days.

Commercial insurers (Highmark Blue Cross Blue Shield Delaware, Aetna, United Healthcare plans sold in Delaware) vary. Some cover Armour Thyroid on Tier 2 or Tier 3 without PA; others require documentation of levothyroxine failure. Call the number on your insurance card or check your plan's online formulary before the appointment to avoid delays.

503A Compounding Pharmacies and NDT in Delaware

A 503A pharmacy is a traditional compounding pharmacy operating under state board of pharmacy regulation and section 503A of the Federal Food, Drug, and Cosmetic Act. In Delaware, 503A pharmacies are licensed by the Delaware Division of Professional Regulation and may compound natural desiccated thyroid preparations for individual patients with a valid prescription.

This matters for two practical reasons. First, standard Armour Thyroid tablet strengths jump in somewhat large increments (30 mg, 60 mg, 90 mg). A 503A compounder can prepare a 45 mg or 75 mg NDT capsule when fine-titration is needed during the early dose-optimization phase. Second, Armour Thyroid has experienced intermittent national supply constraints. Delaware-based 503A pharmacies sourcing USP-grade desiccated thyroid powder can serve as a backup supply when retail tablets are on back order.

503A compounding pharmacies in Delaware must compound only upon receipt of a patient-specific prescription. They cannot compound large batches for anticipatory dispensing. If your telehealth provider sends your prescription to a 503A compounder, confirm the pharmacy holds an active Delaware pharmacy license before transferring. The Delaware Board of Pharmacy license lookup is available through the Division of Professional Regulation online portal.

Shipping from a Delaware-licensed 503A pharmacy to a Delaware address is permitted. Shipping from an out-of-state 503A pharmacy to a Delaware patient is also permitted if the originating pharmacy holds an active non-resident pharmacy license in Delaware.

Dosing, Titration, and Monitoring After Starting in Delaware

Armour Thyroid dosing is expressed in milligrams (mg) or in grains (one grain equals 60 mg). Starting doses for most adults with primary hypothyroidism range from 30 mg (half a grain) to 60 mg (one grain) daily. Patients transferring from levothyroxine use a conversion ratio: approximately 100 mcg levothyroxine converts to roughly 60 mg (one grain) of Armour Thyroid, though individual response varies enough that this ratio is a starting estimate, not a fixed rule.

Take Armour Thyroid on an empty stomach, at least 30 to 60 minutes before eating. Calcium, iron supplements, antacids containing aluminum or magnesium, and high-fiber foods all reduce absorption. Coffee specifically reduces levothyroxine absorption by up to 36% when taken within 60 minutes of dosing; the same interaction applies to DTE because it contains T4 (6).

Recheck TSH and Free T3 at 6 weeks after each dose change. The target TSH on DTE tends to run slightly lower than on levothyroxine monotherapy in patients who feel well; many DTE-prescribing clinicians aim for a TSH between 0.5 and 2.0 mIU/L in the absence of cardiovascular contraindications. Free T3 should remain within the upper half of the reference range, not above it, to avoid T3 excess symptoms such as palpitations, tremor, or heat intolerance.

Once a stable dose is reached, annual monitoring with TSH and Free T3 is adequate for most patients. Pregnancy changes the target immediately: TSH should be maintained below 2.5 mIU/L in the first trimester, and dose requirements commonly increase by 20 to 30% as early as week 4 to 6 of gestation (7).

Transferring an Existing Armour Thyroid Prescription to Delaware

If you are relocating to Delaware with an active Armour Thyroid prescription from another state, the transfer process is straightforward at the pharmacy level. A Delaware retail pharmacy can accept a transferred prescription from an out-of-state pharmacy for any non-controlled medication, including Armour Thyroid.

The prescriber's license, however, does not transfer. Your out-of-state physician cannot continue prescribing for you as a Delaware resident once you establish Delaware residency, unless they hold an active Delaware medical license or an active interstate telehealth license valid in Delaware. You have up to the number of remaining refills on the transferred prescription to establish care with a Delaware-licensed provider and receive a new prescription.

If you are temporarily in Delaware (student, seasonal resident, short-term assignment) and your out-of-state physician uses a telehealth platform licensed in Delaware, that provider may legally continue your care and issue refill prescriptions without you needing to establish with a new local provider.

Cost Without Insurance in Delaware

Armour Thyroid retail cash pricing at Delaware pharmacies ranges from approximately $30 to $80 per month for doses between 60 mg and 120 mg daily, depending on pharmacy and tablet strength. GoodRx and similar discount programs consistently bring the price below $50 per month at major chains in Wilmington and Dover.

Compounded NDT from a Delaware 503A pharmacy runs approximately $40 to $90 per month depending on dose and capsule count, and is rarely covered by insurance because compounded drugs are not FDA-approved finished drug products.

The Allergan patient assistance program (AbbVie Cares, since Allergan is now an AbbVie company) offers cost support for commercially insured patients with high out-of-pocket costs and for uninsured patients meeting income criteria. Eligibility and application details are available through the manufacturer directly; your HealthRX clinician can provide documentation letters to support an assistance program application.